Michael James Roberts - 17 May 2023 Form 4 Insider Report for Lumen Technologies, Inc. (LUMN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 May 2023, 17:28:52 UTC
Prior SEC filing
02 Mar 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gary Maxwell ("Max") Cox, as Attorney-in-Fact for Michael James Roberts

Key filing fact

Michael James Roberts filed Form 4 for Lumen Technologies, Inc. (LUMN) on 19 May 2023.

Key facts

  • This page summarizes Michael James Roberts's Form 4 filing for Lumen Technologies, Inc. (LUMN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 May 2023, 17:28.

Change

  • Previous filing in this sequence was filed on 02 Mar 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LUMN transaction

Common Stock

Award

Transaction value
$0
Shares
+85,605
Change %
+75%
Price
$0.000000
Shares after
199,056
Date
17 May 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This grant of restricted stock will vest on May 17, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .